Which is the best lipid-modifying strategy in metabolic syndrome and diabetes fibrates, statins or both 英文论文文献.docVIP

Cardiovascular Diabetology BioMedCentral Editorial Open Access Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both? Alexander Tenenbaum1,2 and Enrique Z Fisman*1,2 Address: 1Cardiac Rehabilitation Institute, the Chaim Sheba Medical Center, 52621 Tel-Hashomer, Ramat-Gan, Israel and 2Sackler Faculty of Medicine, Tel-Aviv University, 69978 Ramat-Aviv, Tel-Aviv, Israel Email: Alexander Tenenbaum - altenen@post.tau.ac.il; Enrique Z Fisman* - zfisman@post.tau.ac.il * Corresponding author Published: 01 December 2004 Received: 01 December 20